Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus

Journal of Virology

Volumn 86, Issue 15, 2012, Pages 8086-8096

  Yu, Xianming ^a   McCarthy, Patrick J ^a   Wang, Zhenxun ^a   Gorlen, Daniel A ^a   Mertz, Janet E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; EARLY ANTIGEN DIFFUSE PROTEIN; IMMEDIATE EARLY PROTEIN BZLF1; RTA PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BINDING SITE; BLLF1 GENE; BMRF1 GENE; BRLF1 GENE; BZLF1 GENE; CELL IMMORTALIZATION; CELL STRAIN HEK293; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS INFECTIVITY; VIRUS LATENCY; VIRUS MUTATION; VIRUS STRAIN;

ANTIGENS, VIRAL; B-LYMPHOCYTES; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; MUTATION; RNA, MESSENGER; RNA, VIRAL; SILENCER ELEMENTS, TRANSCRIPTIONAL; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 84864388654     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00234-12     Document Type: Article

References (56)

1. Altmann M, Hammerschmidt W. 2005. Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol. 3:e404. doi:10.1371/journal.pbio.0030404.
2. Altmann M, et al. 2006. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc. Natl. Acad. Sci. U. S. A. 103:14188-14193.
3. Bell AI, et al. 2006. Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J. Gen. Virol. 87:2885-2890.
4. Bergbauer M, et al. 2010. CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog. 6:e1001114. doi:10.1371/ journal.ppat.1001114.
5. Bhende PM, Dickerson SJ, Sun X, Feng WH, Kenney SC. 2007. X-boxbinding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J. Virol. 81:7363-7370.
6. Borras AM, Strominger JL, Speck SH. 1996. Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction. J. Virol. 70:3894-3901.
7. Bryant H, Farrell PJ. 2002. Signal transduction and transcription factor modification during reactivation of Epstein-Barr virus from latency. J. Virol. 76:10290-10298.
8. Cahir-McFarland E, Kieff E. 2005. Epstein-Barr virus latent infection membrane protein one, p 553-570. In Robertson ES (ed), Epstein-Barr virus. Caister Academic Press, Norwich, United Kindom.
9. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W. 1998. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. U. S. A. 95:8245-8250.
10. Ellis AL, Wang Z, Yu X, Mertz JE. 2010. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. J. Virol. 84:6139-6152.
11. Ellis-Connell AL, Iempridee T, Xu I, Mertz JE. 2010. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication. J. Virol. 84:10329-10343.
12. Feederle R, et al. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19:3080-3089.
13. Feng WH, et al. 2007. ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells. J. Virol. 81:10113-10122.
14. Flamand L, Menezes J. 1996. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6. J. Virol. 70:1784-1791.
15. Flemington E, Speck SH. 1990. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1227-1232.
16. Goentoro LA, Yakoby N, Goodhouse J, Schupbach T, Shvartsman SY. 2006. Quantitative analysis of the GAL4/UAS system in Drosophila oogenesis. Genesis 44:66-74.
17. Halder S, et al. 2009. Early events associated with infection of Epstein-Barr virus infection of primary B-cells. PLoS One 4:e7214. doi:10.1371/ journal.pone.0007214.
18. Hilscher C, Vahrson W, Dittmer DP. 2005. Faster quantitative real-time PCR protocols may lose sensitivity and show increased variability. Nucleic Acids Res. 33:e182. doi:10.1093/nar/gni181.
19. Huang J, et al. 2006. Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells. J. Virol. 80: 1098-1109.
20. Iempridee T, Das S, Xu I, Mertz JE. 2011. Transforming growth factor β-induced reactivation of Epstein-Barr virus involves multiple Smadbinding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene. J. Virol. 85:7836-7848.
21. Israel BF, Kenney SC. 2005. EBV lytic infection, p 571-611. In Robertson ES (ed), Epstein-Barr virus. Caister Academic Press, Norfolk, United Kingdom.
22. Junying J, et al. 2003. Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma. Virology 306:236-243.
23. Kalla M, Hammerschmidt W. 2012. Human B cells on their route to latent infection- early but transient expression of lytic genes of Epstein-Barr virus. Eur. J. Cell Biol. 91:65-69.
24. Kalla M, Göbel C, Hammerschmidt W. 2012. The lytic phase of Epstein-Barr virus requires a viral genome with 5-methylcytosine residues in CpG sites. J. Virol. 86:447-458.
25. Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W. 2010. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc. Natl. Acad. Sci. U. S. A. 107:850-855.
26. Katsumura KR, Maruo S, Takada K. 2012. EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes. J. Med. Virol. 84:504-510.
27. Kenney SC. 2007. Reactivation and lytic replication of EBV. Chapter 25 In Arvin A, et al (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
28. Kenney S, et al. 1989. The Epstein-Barr virus (EBV) BZLF1 immediateearly gene product differentially affects latent versus productive EBV promoters. J. Virol. 63:1729-1736.
29. Kieff E, Rickinson AB. 2007. Epstein-Barr virus and its replication, p 2603-2654. In Knipe DM, Howley PM (ed), Fields virology, 5th ed, vol 2. Lippincott/Williams & Wilkins Co., Philadelphia, PA.
30. Kraus RJ, Perrigoue JG, Mertz JE. 2003. ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus. J. Virol. 77:199-207.
31. Kraus RJ, Mirocha SJ, Stephany HM, Puchalski JR, Mertz JE. 2001. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. J. Virol. 75:867-877.
32. Liang CL, Chen JL, Hsu YP, Ou JT, Chang YS. 2002. Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-β through cooperativity of Smads and c-Jun/c-Fos proteins. J. Biol. Chem. 277:23345-23357.
33. Lin Z, Flemington EK. 2010. Regulation of EBV latency by viral lytic proteins, p 167-192. In Robertson ES (ed), Epstein-Barr virus: latency and transformation. Caister Academic Press, Norwich, United Kingdom.
34. Lin Z, et al. 2010. Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429. J. Virol. 84:7892-7897.
35. Liu P, Liu S, Speck SH. 1998. Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter. J. Virol. 72:8230-8239.
36. Liu S, Borras AM, Liu P, Suske G, Speck SH. 1997. Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. Virology 228: 11-18.
37. Liu S, Liu P, Borras A, Chatila T, Speck SH. 1997. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 16:143-153.
38. -ΔΔCt method. Methods 25: 402-408.
39. Ma S-D, et al. 2012. An Epstein-Barr virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J. Virol. 86:7976-7987.
40. Miller CL, et al. 1995. Integral membrane 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinase. Immunity 2:155-166.
41. Montalvo EA, Cottam M, Hill S, Wang Y-C J. 1995. YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter. J. Virol. 69:4158-4165.
42. Montalvo EA, Shi Y, Shenk TE, Levine AJ. 1991. Negative regulation of the BZLF1 promoter of Epstein-Barr virus. J. Virol. 65:3647-3655.
43. Remacle JE, et al. 1999. New mode of DNA binding of multi-zinc finger transcription factors: δEF1 family members bind with two hands to two target sites. EMBO J. 18:5073-5084.
44. Rickinson AB, Kieff E. 2007. Epstein-Barr virus and its replication, p 2656-2700. In Knipe DM, Howley PM (ed), Fields virology, 5th ed, vol 2. Lippincott/Williams & Wilkins Co., Philadelphia, PA.
45. Ryan JL, et al. 2004. Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J. Mol. Diagn. 6:378-385.
46. Schwarzmann F, et al. 1994. Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1. J. Gen. Virol. 75:1999-2006.
47. Speck SH, Chatila T, Flemington E. 1997. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5:399-405.
48. Sun CC, Thorley-Lawson DA. 2007. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J. Virol. 81:13566-13577.
49. Thomas C, Dankesreiter A, Wolf H, Schwarzmann F. 2003. The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency. J. Gen. Virol. 84:959-964.
50. Wang Y-C, Huang JM, Montalvo EA. 1997. Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1. Virology 227:323-330.
51. Wen W, et al. 2007. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J. Virol. 81:1037-1042.
52. Wu FY, et al. 2004. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle. J. Virol. 78:4847-4865.
53. Yu X, et al. 2011. The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency. J. Virol. 85:5081-5090.
54. Yu X, Wang Z, Mertz JE. 2007. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus. PLoS Pathog. 3:e194. doi:10.1371/ journal.ppat.0030194.
55. Zetterberg H, Rymo L. 2005. EBNA2 transcriptional regulation in EBV latency, p 439-462. In Robertson ES (ed), Epstein-Barr virus. Caister Academic Press, Norwich, United Kingdom.
56. Zuo J, et al. 2011. Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2. PLoS Pathog. 7:e1002455. doi:10.1371/ journal.ppat.1002455.